Listing 1 - 8 of 8 |
Sort by
|
Choose an application
ROS were long considered one of the key players in tissue injury. Indeed, overproduction of ROS results in oxidative stress, a process leading to the development of many pathological conditions. For the treatment of these conditions, the use of antioxidants was proposed. Over time, it was shown that ROS at low concentrations act as signaling molecules, leading to the regulation of physiological functions. Moreover, several interventions that increase ROS generation activate stress-adaptive responses that extend the lifespan. It was also shown that excessive use of antioxidants can counter the beneficial effects of ROS. Currently, much progress has been made in understanding the role of ROS in human diseases and aging, as well as in the regulation of physiological functions, and in identifying the signaling pathways involved in ROS. However, much remains to be understood about the mutual interactions among signaling pathways underlying organisms’ adaptive responses, their modifications (which occur during aging), and some disease states. The aim of this Special Issue is to underline the effects of ROS production and antioxidant treatment in living organisms, focusing on their impact on health, disease, and aging.
Research & information: general --- Biology, life sciences --- CTCL --- apoptosis --- cell viability --- c-FLIP --- XIAP --- artemisinin --- SH-SY5Y cells --- hippocampal neurons --- H2O2 --- AMPK pathway --- atherosclerosis --- sphingomyelin synthase 2 --- endothelial dysfunction --- endoplasmic reticulum stress --- β-catenin --- insulin resistance --- cancer --- cardiovascular disease --- neurodegenerative disorders --- exercise --- mitochondria --- oxidative stress --- PGC-1 --- Nrf2 --- UCPs --- ROS --- light --- DNA damage --- evolution --- D-box --- cavefish --- Spalax --- trimethylamine N-oxide --- cardiomyocytes --- cardiotoxicity --- mitochondrial membrane potential --- CORM-2 --- NADPH oxidase --- AP-1 --- HO-1 --- Renal cell carcinoma (RCC) --- reactive oxygen species (ROS) --- glutathione (GSH) metabolism --- cancer therapy --- clear cell RCC --- papillary RCC --- chromophobe RCC --- sarcopenia --- reactive oxygen species --- redox signaling --- antioxidant supplementation --- protein aggregation --- redox --- proteinopathy --- peroxiredoxins --- tumorigenesis --- ROS scavengers --- n/a
Choose an application
This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.
Medicine --- renal cell carcinoma --- autophagy --- hydroxychloroquine --- chloroquine --- ROC-325 --- cysteine cathepsins --- cysteine cathepsin inhibitors --- lysosome --- renal cancer --- metastatic renal cell carcinoma --- immune-based combination therapies --- network meta-analysis --- PD-L1 --- predictive --- biomarker --- treatment --- TKIs --- mRCC --- biomarkers --- soluble factors --- immunotherapy --- renal cell carcinoma (RCC) --- sunitib resistance --- artesunate (ART) --- Traditional Chinese Medicine (TCM) --- growth inhibition --- ferroptosis --- reactive oxygen species (ROS) --- clear cell renal cell carcinoma --- ccRCC --- RCC --- kidney cancer --- evolution --- evolutionary trajectory --- metastatic --- second line therapy --- renal cell cancer --- immune checkpoint inhibitors --- tyrosine kinase inhibitors --- individualization --- genomic signature --- transcriptomic analysis
Choose an application
This book systematically illustrates the dynamic mechanical behaviors and discusses the fundamentals of the constitutive modeling of roller-compacted concrete (RCC), influenced by the construction technique and mix design. Four typical problems are analyzed using laboratory tests, numerical simulation and theoretical analysis, i.e., to illustrate the special dynamic mechanical behaviors of RCC, to reveal the dynamic size-dependence of mechanical properties, to discuss the aggregate size effect on dynamic mechanical properties, and to modify the dynamic constitutive model for RCC. Generally, the constitutive modeling of RCC needs a comprehensive understanding of dynamic size-dependence and aggregate size effect of concrete that coupled with the strain-rate sensitivity. So that, readers can master the modified dynamic constitutive model of RCC to analyze and solve the problems in blast-resistance analysis and protective design of RCC dams. This book can be used as a postgraduate textbook for civil and hydraulic engineering in colleges and universities, and as an elective course for senior undergraduates. It can also be used as a reference for relevant professional scientific researchers and engineers in field of protective design of concrete structures.
Rock mechanics. --- Soil mechanics. --- Foundations. --- Engineering geology. --- Soil and Rock Mechanics. --- Foundation Engineering. --- Engineering --- Civil engineering --- Geology, Economic --- Architecture --- Building --- Structural engineering --- Underground construction --- Caissons --- Earthwork --- Masonry --- Soil consolidation --- Soil mechanics --- Walls --- Soil engineering --- Soils --- Soils (Engineering) --- Geotechnical engineering --- Mechanics --- Foundations --- Soil physics --- Geology --- Details --- Roller compacted concrete. --- Concrete, Roller compacted --- RCC (Roller compacted concrete) --- Rollcrete --- Rolled concrete --- Concrete
Choose an application
This Urological Cancer 2020 collection contains a set of multidisciplinary contributions to the extraordinary heterogeneity of tumor mechanisms, diagnostic approaches, and therapies of the renal, urinary tract, and prostate cancers, with the intention of offering to interested readers a representative snapshot of the status of urological research.
Research & information: general --- Biology, life sciences --- renal cell carcinoma --- iron --- macrophages --- chelation therapy --- urothelial carcinoma --- transcriptome --- microtubule --- MAP1B --- prognosis --- KLF5 --- androgen receptor --- cell proliferation --- tumorigenesis --- prostate cancer --- precision medicine --- whole genome sequencing --- optical mapping --- therapy --- prostate carcinoma --- prostate mpMRI --- machine learning --- artificial intelligence --- deep learning --- neural network --- angiogenesis --- angiogenic growth factors --- antiangiogenic therapy --- renal tumors --- prevention --- α1-adrenoceptor antagonists --- anoikis --- vascularity --- research model --- oncogenes --- tumor suppressor genes --- MR-guided --- radiotherapy --- MRgRT --- stereotactic ablative radiotherapy --- stereotactic ablative radiation therapy (SABR) --- renal cell cancer --- RCC --- online adaptive --- [68Ga]Ga-PSMA PET/CT --- dual-time point imaging --- delayed imaging --- biphasic imaging --- lesion positivity rate --- CXCL9 --- PD1 --- PD-L1 --- stage T1 NMIBC --- prostatic neoplasms/mortality --- prostatic neoplasms/epidemiology --- SEER Program --- bladder cancer --- transurethral resection --- en-bloc resection --- CPT1A --- fatty acids --- serine --- androgen response --- ROS --- oxidative stress --- DONSON --- Downstream Neighbor of SON --- biomarker --- metastatic spread --- diagnosis --- differential diagnosis --- histopathology --- immunohistochemistry --- stroma signature --- patient-derived xenografts --- n/a --- Research. --- Biology.
Choose an application
MicroRNAs (miRs) are small noncoding RNAs that function as post-transcriptional regulators of gene expression and have important roles in almost all biological pathways. Deregulated miR expression has been detected in numerous cancers, where miRs act as both oncogene and tumor suppressors. Due to their important roles in tumorigenesis, miRs have been investigated as prognostic and diagnostic biomarkers and as useful targets for therapeutic intervention. From a therapeutic point of view, two modalities can serve to rectify gene networks in cancer cells. For oncomiRs, a rational means is downregulation through antagomirs. Moreover, observations of the pathological reductions in tumor-suppressive miRs have inspired the concept of “miR replacement therapy” to enhance the amount of these miRs, thereby restoring them to normal levels. However, the clinical applicability of miR-based therapies is severely limited by the lack of effective delivery systems. Therefore, to understand the role of this new class of regulators, we need to identify the mRNA targets regulated by individual miRs as well as to develop specific, efficient, and safe delivery systems for therapeutic miRs.
Research & information: general --- Biology, life sciences --- Breast cancer --- Hypoxia inducible factor 1-alpha (HIF-1α) --- MicroRNA (miRNA) --- miR526b --- miR655 --- Oxidative stress --- Migration --- Cyclooxygenase-2 (COX-2) --- Prostaglandin E2 receptor 4 (EP4) --- PI3K/Akt --- adipokines --- endometrial cancer --- estrogens --- hyperinsulinemia --- insulin --- insulin resistance --- insulin signaling --- insulin-like growth factors --- microRNA --- miRNA --- ovarian cancer --- survival --- prognostic factor --- serum LDH --- blood biomarker --- circulating microRNA --- plasma --- immunotherapy --- immune checkpoint inhibitors --- metastatic melanoma --- hepatocellular carcinoma --- metastasis --- exosome --- bioinformatics analysis --- renal cancer --- RCC --- ccRCC --- meta-analysis --- miRNAs --- normal B-cell development --- B-CLL --- miRNA-transcription factor network --- regulation --- biomarker --- therapy --- prognosis --- diagnosis --- progression --- prediction --- smoking --- non-small cell lung cancer --- methylation --- miR-584-5p --- YKT6 --- snoRNA --- 2′-O-methylation --- pseudouridylation --- malignant melanoma --- cancer stem cell --- stemness --- head and neck squamous cell carcinoma --- colon cancer --- cancer stem cells --- microRNAs --- deformability --- PARP --- replication stress --- targeted therapy --- breast cancer --- circulating biomarkers --- medulloblastoma --- brain tumour --- subgroups --- stem cells --- n/a --- 2'-O-methylation
Choose an application
Cantors made unparalleled contributions to the way time was understood and history was remembered in the medieval Latin West. The men and women who held this office in cathedrals and monasteries wereresponsible for calculating the date of Easter and the feasts dependent on it, for formulating liturgical celebrations season by season, managing the library and preparing manuscripts and other sources necessary to sustain the liturgical framework of time, and promoting the cults of saints. Crucially, their duties also often included committing the past to writing, from simple annals and chronicles to more fulsome histories, necrologies, and cartularies, thereby ensuring that towns, churches, families, and individuals could be commemorated for generations to come.
The contributions hereseek to address the fundamental question of how the range of cantors' activities can help us to understand the many different ways in which the past was written and, in the liturgy, celebrated acrossthe middle ages. Cantors, as this volume makes clear, shaped the communal experience of the past in the Middle Ages; the essays are studies of constructions, both of the building blocks of time and ofthe people who made and performed them, in acts of ritual remembrance and in written records.
Contributors: Cara Aspesi, Alison I. Beach, Katie Ann-Marie Bugyis, Margot E. Fassler, David Ganz, James Grier, Paul Antony Hayward, A.B. Kraebel, Lori Kruckenberg, Rosamond McKitterick, Henry Parkes, Susan Rankin, C.C. Rozier, Sigbjoryn Olsen Sonnesyn, Teresa Webber, Lauren Whitnah,
Church history --- Church music --- Civilization, Medieval --- Pastoral music (Sacred) --- Religious music --- Sacred vocal music --- Devotional exercises --- Liturgics --- Music --- Music in churches --- Psalmody --- History and criticism --- Religious aspects --- Christianity --- Cantors (Church music) --- Chantres --- Eglise --- Musique d'église --- Civilisation médiévale --- Histoire --- Musique d'église --- Civilisation médiévale --- Church history -- Middle Ages --- Historiography --- Middle Ages --- Catholic Church --- History --- Katholische Kirche --- 500-1500 --- Church musicians --- Historical criticism --- Authorship --- Criticism --- Katolikus Egyház --- RCC --- Katoličeskaj Cerkovʹ --- Katoličke Cerkve --- Katolska Cyrkej --- Katolske Kirke --- Ecclesia Catholica --- Igreja Católica --- Römisch-Katholische Kirche --- Katholikē Ekklēsia --- Roman Catholic Church --- Eglise Catholique --- Eglise Catholique Romaine --- Chiesa Cattolica --- Katholieke Kerk --- Iglesia Católica --- Katolické Církve --- Kościoł Katolicki --- Katoličke Crkve --- Eglise catholique romaine --- Chiesa cattolica romana --- Roman catholic Church --- Eglise catholique --- Römische Kirche --- Kirche --- Katholizismus --- Unierte Ostkirchen --- Medieval Period --- Christian church history --- History of Europe --- anno 500-1499 --- Cantors. --- Catholic Church. --- Christianity. --- Church History. --- Church music. --- Divine Office. --- Historiography. --- Liturgy. --- Medieval Europe. --- Medieval Latin West. --- Middle Ages. --- Necrologies. --- Prayer. --- Religion. --- Ritual Remembrance. --- Sacred song. --- Saint.
Choose an application
Nineteenth-century female congregation founders could achieve levels of autonomy, power and prestige that were beyond reach for most women of their time. With a subject hidden for a long time behind a curtain of modesty and mystery, this book recounts the fascinating but ambiguous life stories of four Belgian religious women. A close reading of their personal writings unveils their conflicted existence: ambitious, engaged and bold on the one hand, suffering and isolated on the other, they were both victims and promotors of a nineteenth-century ideal of female submission. As religious and social entrepreneurs these women played an influential role in the revival of the church and the development of education, health care and social provisions in modern Belgium. But, equally well, they were bound to rigid gender patterns and adherents of an ultramontane church ideology that fundamentally distrusted modern society.
C2 --- religieuzen --- vrouwen --- geloofsleven --- KADOC - Documentatie- en Onderzoekscentrum voor Religie, Cultuur en Samenleving (1977-) --- Religieuze instituten --- Christian religious orders --- Sociology of the family. Sociology of sexuality --- Autonomie. --- Frau. --- Geschlechterforschung. --- Ordensgründerin. --- Unterdrückung. --- Katholische Kirche. --- Belgien. --- Nuns --- Women in the Catholic Church --- Religieuses --- Femmes dans l'Eglise catholique --- History --- Histoire --- Feminist theology --- Theology, Feminist --- Theology, Doctrinal --- Sisters (in religious orders, congregations, etc.) --- Christians --- Monasticism and religious orders for women --- Women in the Catholic Church. --- Feminist theology. --- History. --- Kloosterleven--België--geschiedenis --- Vrouwen --- 245.4 --- Kloosterwezen--België--geschiedenis --- Vrouwen in de kerk --- Belgium --- Bäigien --- Baljīk --- Belchica --- Belçika --- Belçika Krallığı --- Beldjym --- Belezi --- Belga Királyság --- Beļgeja --- Belghia --- Belʹgi --- Bèlgia --- Belgia Kuningriik --- Bélgica --- Belgice --- Belgice Cynerīce --- Belgické královstv --- Belgi --- Belgien --- Bélgii Bikéyah --- Belgii͡ --- Belʹgii͡a Korollege --- Belgija --- Beļg̓ijas Karaliste --- Belgijos Karalyst --- Belgijsk --- Belgika --- Belgio --- Belgique --- Belgiska --- Belgiya --- Belgiyah --- Belgje --- Belgjiche --- Belgjo --- Belgujo --- Belʹhii͡ --- Belhika --- Bèljik --- Beljika --- Belʹjmudin Nutg --- Belsch --- Belsj --- Bélxica --- Berug --- Bheilg --- Bilgasuyu --- Bilhika Qhapaqsuyu --- Bilkiya --- Gwlad Belg --- Igihugu cyʼUbubirigi --- Karaleŭstva Belʹhii͡ --- Keuninkriek Belsj --- Kingdom of Belgium --- Kinigraich Bäigien --- Kinnekräich Belsch --- Kongeriget Belgien --- Königreich Belgien --- Königriich Belgie --- Koninkrijk Belgi --- Koninkrijk van Belgi --- Koninkryk van Belgi --- Kraljevina Belgija --- Kralojstwo Belgiskej --- Mamlakat Baljīk --- Mamlekhet Belgiyah --- Nsi ya ntotila ya Belezi --- Pelekiuma --- Pow Belg --- Reeriaght ny Belg --- Reĝlando Belgio --- Regne de Bèlgica --- Regno del Belgio --- Reino de Belchica --- Reino de Bélgica --- Reinu de Bélxica --- Ríocht na Beilge --- Rìoghachd na Beilge --- Royaume de Belgique --- Royômo de Bèlg·ique --- Ruwvaneth Belgek --- Teyrnas Gwlad Belg --- Ubelgiji --- Ububiligi --- Ububirigi --- Ufalme wa Ubelgiji --- Vasileio tou Velgiou --- Vãsilia di Belghia --- Velg --- Velgio --- Meeûs, Anna de, --- Kestre, Fanny, --- Cornet, Antoinette, --- Telghuys, Wilhelmina, --- Börngen, ... --- Katholische Kirche --- 1800-1899 --- Börngen, ... --- ... --- Düsseldorf --- Leser, Rosalie --- De Meeûs, Anna, --- Katolikus Egyház --- RCC --- Katoličeskaj Cerkovʹ --- Katoličke Cerkve --- Katolska Cyrkej --- Katolske Kirke --- Ecclesia Catholica --- Igreja Católica --- Römisch-Katholische Kirche --- Katholikē Ekklēsia --- Catholic Church --- Roman Catholic Church --- Eglise Catholique --- Eglise Catholique Romaine --- Chiesa Cattolica --- Katholieke Kerk --- Iglesia Católica --- Katolické Církve --- Kościoł Katolicki --- Katoličke Crkve --- Eglise catholique romaine --- Chiesa cattolica romana --- Roman catholic Church --- Eglise catholique --- Römische Kirche --- Kirche --- Katholizismus --- Unierte Ostkirchen
Choose an application
Renal cancer is a health problem of major concern worldwide. Although tyrosine kinase inhibitors and immune check-point blockade treatments, alone or in combination, are giving promising results, failures are quite frequent due to intratumor heterogeneity and to the acquisition of drug resistance. The spectrum of renal cell carcinoma subtypes is wide. Up to 70–80% of renal tumors are clear cell renal cell carcinomas, a clinically aggressive tumor subtype linked to VHL gene inactivation. Next in frequency, the papillary renal cell carcinoma category encompasses an intricate puzzle of classic and newly described entities with poorly defined limits, some of them pending definite clarification. Likewise, the chromophobe–oncocytoma duality, the so-called hybrid tumors and oncocytic neoplasms, remain to be well profiled. Finally, a growing list of very uncommon renal tumors linked to specific molecular signatures fulfill the current portrait of renal cell neoplasia. This Special Issue of Cancers regards RCC from very different perspectives, from the intimate basic mechanisms governing this disease to the clinical practice principles of their diagnoses and treatments. The interested reader will have the opportunity to contact with some of the most recent findings and will be updated with excellent reviews.
Renal cell carcinoma. --- Kidneys --- Cancer. --- Adenocarcinoma of kidney --- Clear cell carcinoma --- Grawitz tumor --- Grawitz's tumor --- Hypernephroid carcinoma --- Hypernephroma --- Renal adenocarcinoma --- Renal cell adenocarcinoma --- Cancer --- N-glycomapping --- n/a --- SMAD proteins --- patient survival --- pro-IL-1? --- survival prediction --- inflammation markers --- tumor migration --- prognostic factors --- practical approach --- circular RNAs in a clinico-genomic predictive model --- glycomarkers --- review --- nephrectomy --- uric acid --- VEGF inhibitors --- metabolic reprogramming --- collecting duct carcinoma --- curcumin --- metabolome profiling --- identification of circular RNAs --- IL-2 --- experimental validation of circular RNA --- Raf/MEK/ERK --- HOT --- PI3K/Akt/mTOR --- pentose phosphate pathway --- kidney cancer --- LOT --- mutation --- RCC --- polybromo-1 --- pale cell --- MMP-9 --- gene expression --- recurrence free survival --- chromosomal loss --- IL-1? --- chronic kidney disease --- glutathione transferase omega 2 --- label-free --- glutathione transferase omega 1 --- emerging entity --- copy number alteration --- FOXO3 --- predictive role --- tumor slice culture --- tyrosine kinase inhibitors --- PPP --- ESC --- CDKN1A expression --- metastasis --- PD-L1 --- diagnostic and prognostic markers --- EVI1 --- copy number loss --- RNA sequencing --- NK cells --- glutathione metabolism --- clear cell renal cell carcinoma --- renal cell cancer --- proliferation --- eosinophilic variant --- Xp11 translocation renal cell carcinoma --- prognosis --- invasion --- immune infiltration --- IL4R? --- FISH --- 11) translocation renal cell carcinoma --- tumor microenvironment --- metabolome --- hyperosmolality --- toxicity --- ALK --- drug sensitivity --- t(6 --- copy number analysis --- urine --- genetic association --- polymorphism --- solute carrier proteins --- kidney --- metastatic ccRCC --- molecular genetic features --- recurrence-free survival --- chromophobe renal cell carcinoma --- unclassified renal tumor --- overall survival --- mTOR inhibitors --- mTOR --- JAK2 --- von Hippel–Lindau --- miR-155-5p --- glycoproteomics --- PBRM1 --- miR-133b --- survival --- TFE3 --- TFEB --- oncocytic renal tumor --- immune checkpoint inhibitors --- biomarker --- MMP10 --- TCGA --- ghrelin --- EMT like --- checkpoint inhibitors --- MiT family translocation renal cell carcinoma --- gene signature --- sarcomatoid --- transforming growth factor beta --- clear cell Renal Cell Carcinoma --- tumor adhesion --- renal cancer --- unclassified renal cell carcinoma --- Papillary renal cell carcinoma (pRCC) --- miR-146a-5p --- renal cell --- everolimus --- integrins --- cytoreductive nephrectomy --- immunotherapy --- predictive factors --- immunohistochemistry --- MTA2 --- IL13R?1 --- targeted therapy --- intratumour heterogeneity --- aurora A --- TCA cycle --- AMP-activated protein kinases --- cancer-specific survival --- programmed death-ligand 1 --- efficacy --- renal cell carcinoma --- anaplastic lymphoma kinase rearrangement --- TFEB-amplified renal cell carcinoma --- statins --- cancer immunotherapy --- microRNA --- new entity --- proteome profiling --- von Hippel-Lindau
Listing 1 - 8 of 8 |
Sort by
|